Win Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-145
Closed -$4.05K 108
2022
Q4
$4.05K Hold
145
﹤0.01% 119
2022
Q3
$3K Hold
145
﹤0.01% 117
2022
Q2
$5K Sell
145
-3,696
-96% -$129K 0.01% 142
2022
Q1
$134K Buy
+3,841
New +$131K 0.04% 75

Other funds holding OGN

Win Advisors's OGN Position: Q1 2023 in Review

Win Advisors sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 145 shares — an estimated $4.05K sold.

Win Advisors first reported a position in OGN in Q1 2022 and held it in 4 quarters. The position peaked at $134K in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Win Advisors reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Win Advisors sold 145 Organon & Co shares in Q1 2023, an estimated $4.05K.
  • Win Advisors first reported a position in Organon & Co in Q1 2022 and held it in 4 quarters.
  • Win Advisors's Organon & Co position peaked at $134K in Q1 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Win Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.